Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death

por El-Sewedy, Tarek, Salama, Afrah Fatthi, Mohamed, Amro E., Elbaioumy, Nashwa M., El-Far, Ali H., Albalawi, Aisha Nawaf, Elmetwalli, Alaa
Publicado 2023

Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches

por El-Shehawy, Ashraf A., Elmetwalli, Alaa, El-Far, Ali H., Mosallam, Sahar Abd El-Razik, Salama, Afrah Fatthi, Babalghith, Ahmad O., Mahmoud, Mohammad A., Mohany, Hany, Gaber, Mohamed, El-Sewedy, Tarek
Publicado 2023